anmelden
Sanofi Aktie
76,42
EUR
-0,31
EUR
-0,40
%
76,39
EUR
-0,21
EUR
-0,27
%
Sanofi jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Sanofi Aktie Analyse
| 29.03.22 | Sanofi Buy | UBS AG | |
| 29.03.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 29.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 25.03.22 | Sanofi Outperform | Credit Suisse Group | |
| 24.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 24.03.22 | Sanofi Buy | UBS AG | |
| 21.03.22 | Sanofi Outperform | Bernstein Research | |
|
Werbung
|
|||
| 17.03.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 14.03.22 | Sanofi Buy | UBS AG | |
| 14.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 08.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 08.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.03.22 | Sanofi Buy | UBS AG | |
| 11.02.22 | Sanofi Buy | UBS AG | |
| 07.02.22 | Sanofi Outperform | Credit Suisse Group | |
| 04.02.22 | Sanofi Buy | UBS AG | |
| 04.02.22 | Sanofi Outperform | Bernstein Research | |
| 04.02.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 04.02.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.01.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 26.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 06.01.22 | Sanofi Buy | UBS AG | |
| 05.01.22 | Sanofi Outperform | Credit Suisse Group | |
| 04.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Sanofi Outperform | Bernstein Research | |
| 15.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 10.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.12.21 | Sanofi Buy | UBS AG | |
| 02.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | Sanofi Buy | Kepler Cheuvreux | |
| 02.12.21 | Sanofi Outperform | Credit Suisse Group | |
| 02.12.21 | Sanofi Buy | UBS AG | |
| 01.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.11.21 | Sanofi Buy | UBS AG | |
| 24.11.21 | Sanofi Buy | UBS AG | |
| 11.11.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 29.10.21 | Sanofi Buy | UBS AG | |
| 29.10.21 | Sanofi Outperform | Credit Suisse Group | |
| 29.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 28.10.21 | Sanofi Overweight | Morgan Stanley | |
| 28.10.21 | Sanofi Outperform | Bernstein Research | |
| 28.10.21 | Sanofi Buy | Kepler Cheuvreux | |
| 28.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 22.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
Werbung
Werbung